April 5, 2016
The laboratory diagnostics industry experienced significant change in 2015, and this year may be just as eventful: CMS will likely finalize a new Medicare payment system; FDA will likely issue final guidance regulating laboratory-developed tests; Congress is considering legislation affecting both payment and regulation; and the United States will elect a new president, setting a new course for health reform more broadly.
McDermott+Consulting's second annual +Dx Diagnostics Forum will explore these changes and provide diagnostics stakeholders with insight on how to succeed in this evolving environment. Its faculty will provide analysis and thoughtful guidance, providing strategic insights into industry changes and political maneuvering.
+Dx will offer expanded networking opportunities, with longer breaks and a reception following the forum where attendees will be able to interact with industry leaders and colleagues.
PMC Executive Vice President Amy M. Miller, Ph.D., will moderate a panel discussion on legislative developments related to the regulation of diagnostic tests during the event.